P. Barton Duell, MD, FNLA, FAHA

Professor of Medicine, Director, Lipid-Atherosclerosis Laboratory, Director, LDL Apheresis Unit, Knight Cardiovascular Institute, Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, OR

Lipid specialist and Endocrinologist in the Center for Preventive Cardiology, Knight Cardiovascular Institute at the Oregon Health and Science University. More than 25 years of experience treating complex and rare genetic lipid disorders, statin intolerance, diabetes, obesity, other metabolic disorders, cardiovascular risk assessment and prevention. Active clinical and research endeavors. International and national speaker on topics related to dyslipidemia, lipoprotein(a), PCSK9, familial hypercholesterolemia, novel drugs for lipid lowering, LDL/lipoprotein apheresis, genetic disorders of sterol metabolism, disabetes, obesity, and other topics.

Recent & Upcoming Conference Sessions

Los Angeles- Cardio

Cardiology Updates Los Angeles

PCSK9 Inhibitors: A Novel Approach to Lowering LDL-C and Cardiovascular Events

Thursday, October 5, 2017

2:50 PM - 4:20 PM